Previous close | 136.70 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 1.27 |
PE ratio (TTM) | 0.69 |
EPS (TTM) | 2.07 |
Earnings date | 06 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, July 09, 2024--IFF (NYSE:IFF) today announced that it will release its second quarter 2024 earnings results following the market close on Tuesday, August 6, 2024. The management team will host a live webcast on Wednesday, August 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community.
IFF today announced EU-wide regulatory approval for two of its groundbreaking feed solutions for poultry. Axtra® XAP – a multi-enzyme blend and Syncra® AVI – an enzyme-probiotic complex from Danisco Animal Nutrition & Health, IFF's Health & Biosciences business unit, are formulated to meet the challenges of modern poultry production and deliver measurable performance improvements.
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...